1. Home
  2. ANIK vs STXS Comparison

ANIK vs STXS Comparison

Compare ANIK & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANIK
  • STXS
  • Stock Information
  • Founded
  • ANIK 1983
  • STXS 1990
  • Country
  • ANIK United States
  • STXS United States
  • Employees
  • ANIK N/A
  • STXS N/A
  • Industry
  • ANIK Medical/Dental Instruments
  • STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • ANIK Health Care
  • STXS Health Care
  • Exchange
  • ANIK Nasdaq
  • STXS Nasdaq
  • Market Cap
  • ANIK 157.8M
  • STXS 151.3M
  • IPO Year
  • ANIK 1993
  • STXS 2004
  • Fundamental
  • Price
  • ANIK $9.65
  • STXS $2.89
  • Analyst Decision
  • ANIK Buy
  • STXS
  • Analyst Count
  • ANIK 1
  • STXS 0
  • Target Price
  • ANIK $15.00
  • STXS N/A
  • AVG Volume (30 Days)
  • ANIK 160.8K
  • STXS 879.8K
  • Earning Date
  • ANIK 07-30-2025
  • STXS 08-07-2025
  • Dividend Yield
  • ANIK N/A
  • STXS N/A
  • EPS Growth
  • ANIK N/A
  • STXS N/A
  • EPS
  • ANIK N/A
  • STXS N/A
  • Revenue
  • ANIK $114,548,000.00
  • STXS $31,806,000.00
  • Revenue This Year
  • ANIK N/A
  • STXS $29.03
  • Revenue Next Year
  • ANIK $9.70
  • STXS $44.05
  • P/E Ratio
  • ANIK N/A
  • STXS N/A
  • Revenue Growth
  • ANIK 16.52
  • STXS 33.94
  • 52 Week Low
  • ANIK $7.87
  • STXS $1.54
  • 52 Week High
  • ANIK $26.48
  • STXS $3.05
  • Technical
  • Relative Strength Index (RSI)
  • ANIK 53.23
  • STXS 66.30
  • Support Level
  • ANIK $8.22
  • STXS $2.73
  • Resistance Level
  • ANIK $9.25
  • STXS $3.05
  • Average True Range (ATR)
  • ANIK 0.45
  • STXS 0.16
  • MACD
  • ANIK 0.16
  • STXS 0.03
  • Stochastic Oscillator
  • ANIK 97.19
  • STXS 81.61

About ANIK Anika Therapeutics Inc.

Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

Share on Social Networks: